RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
9 Meters Biopharma Stock

9 Meters Biopharma Employees 2024

9 Meters Biopharma Employees

12

Ticker

NMTR

ISIN

US6544051096

WKN

A2P362

In 2024, 9 Meters Biopharma employed 12 people, a 0% change from the 12 number of employees in the previous year.

9 Meters Biopharma Aktienanalyse

What does 9 Meters Biopharma do?

9 Meters Biopharma Inc is a company that specializes in researching, developing, and marketing innovative therapeutic treatment options for various chronic diseases. Founded in 2010, the company has since become a major player in the biopharmaceutical drug development industry. The main goal of 9 Meters Biopharma is to provide new and effective treatment options to patients suffering from chronic diseases. The company focuses on the areas of gastroenterology, oncology, autoimmune diseases, and rare diseases. Its business model is based on identifying promising drug candidates and conducting clinical trials to prove the effectiveness and safety of the drugs. Once a drug is successfully developed, the company focuses on marketing and distributing the medication. One of the company's key products is the drug NMIL1701, which is developed for the treatment of patients with celiac disease. The medication targets the breakdown of gluten, which is present in many foods and can cause an inappropriate immune response and chronic inflammation in the intestines of people with celiac disease. Additionally, the company is currently developing medications for the treatment of ulcerative colitis, Crohn's disease, and pancreatitis. It is also researching the development of drugs for the treatment of various cancers and autoimmune diseases, including multiple sclerosis, lupus, and rheumatoid arthritis. Another important aspect of 9 Meters Biopharma's activities is collaborating with other companies and organizations to accelerate and improve drug development. The company works with various academic institutions and research organizations to jointly work on the development of new therapies. Overall, 9 Meters Biopharma Inc has established itself as a dynamic and innovative company in the biopharmaceutical landscape. With its strong focus on the development of novel therapies and collaboration with other organizations, the company is likely to continue playing a major role in improving healthcare and treating chronic diseases. 9 Meters Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining 9 Meters Biopharma's Employee Base

9 Meters Biopharma's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding 9 Meters Biopharma's operational capacity and future potential.

Year-to-Year Comparison

Assessing 9 Meters Biopharma's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

9 Meters Biopharma's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in 9 Meters Biopharma’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about 9 Meters Biopharma stock

How many employees does 9 Meters Biopharma have this year?

9 Meters Biopharma has 12 undefined employees this year.

How many employees did 9 Meters Biopharma have compared to the previous year?

Compared to the previous year, 9 Meters Biopharma had 0% more employees.

What impact did the number of employees have on the company 9 Meters Biopharma?

The number of employees has a direct impact on the efficiency and productivity of 9 Meters Biopharma. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of 9 Meters Biopharma?

The number of employees can also have an impact on investors of 9 Meters Biopharma, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of 9 Meters Biopharma affect the company?

An increase in equity of 9 Meters Biopharma can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in 9 Meters Biopharma's equity affect the company?

A reduction in equity of 9 Meters Biopharma can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of 9 Meters Biopharma?

Some factors that can influence the equity of 9 Meters Biopharma include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of 9 Meters Biopharma so important for investors?

The equity of 9 Meters Biopharma is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at 9 Meters Biopharma influence the company?

The number of employees at 9 Meters Biopharma can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at 9 Meters Biopharma evolved in recent years?

In recent years, the number of employees at 9 Meters Biopharma has changed by 0.

How many employees does 9 Meters Biopharma currently have?

9 Meters Biopharma currently has 12 undefined employees.

Why is the number of employees important for investors of 9 Meters Biopharma?

The number of employees is important for investors of 9 Meters Biopharma as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can 9 Meters Biopharma take to change the number of employees?

To change the number of employees, 9 Meters Biopharma can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does 9 Meters Biopharma pay?

Over the past 12 months, 9 Meters Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 9 Meters Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of 9 Meters Biopharma?

The current dividend yield of 9 Meters Biopharma is .

When does 9 Meters Biopharma pay dividends?

9 Meters Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 9 Meters Biopharma?

9 Meters Biopharma paid dividends every year for the past 0 years.

What is the dividend of 9 Meters Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 9 Meters Biopharma located?

9 Meters Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von 9 Meters Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 9 Meters Biopharma from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did 9 Meters Biopharma pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of 9 Meters Biopharma in the year 2023?

In the year 2023, 9 Meters Biopharma distributed 0 USD as dividends.

In which currency does 9 Meters Biopharma pay out the dividend?

The dividends of 9 Meters Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von 9 Meters Biopharma

Our stock analysis for 9 Meters Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 9 Meters Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.